摘要
慢性硬膜下血肿(chronic subdural hematoma,CSDH)是神经外科常见的继发性颅脑损伤之一,好发于有颅脑创伤史的老年人,随着老龄化的进展,CSDH已经成为影响老年人身体健康与生活质量的重要原因。近年来,CSDH的外科治疗主要以成熟而经典的钻孔引流术为主,但该方法取得一定成效的同时也伴随有CSDH高复发、难治愈的特点,
出处
《中华脑科疾病与康复杂志(电子版)》
2013年第3期4-6,共3页
Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
参考文献26
-
1Berghauser Pont LM, Dammers R, Schouten JW, et al. Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on preoperative corticosteroid therapy. Neurosurgery,2012,70 (4) : 873-880 ; discussion 880.
-
2Dran G, Berthier F, Fontaine D, et al. Effectiveness of adjuvant corticosteroid therapy for chronic subdural hematoma:a retrospective study of 198 cases. Neurochirurgie ,2007,53 (6) :477-482.
-
3Virchow R. Das Hamaton der dura mater. Verch Phys Med Ges Wurzburg, 1857,7 : 134-142.
-
4Schachenmayr W, Friede RL. The origin of subdural neomembranes. I. Fine structure of the dura-arachnoid interface in man. Am J Pathol, 1978,92( 1 ) :53-68.
-
5Markwalder TM, Steinsiepe KF, Rohner M, et al. The course of chronic subdural hematomas after burr-hole craniostomy and closed- system drainage. J Neurosurg, 1981,55 ( 3 ) :390-396.
-
6Suzuki M, Endo S, Inada K, et al. Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir ( Wien ), 1998,140( 1 ) :51-55.
-
7Kitazono M, Yokota H, Satoh H, et al. Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. Neurol Med Chir(Tokyo) ,2012,52 ( 11 ) :810-815.
-
8Charron CE, Chou PC, Coutts DJ, et al. Hypoxia-inducible factor lalpha induces corticosteroid-insensitive inflammation via reduction of histone deacetylase-2 transcription. J Biol Chem,2009,284 (52) : 36047 -36054.
-
9Sakakibara F, Tsuzuki N, Uozumi Y, et al. Chronic subdural hematoma--recurrence and prevention. Brain Nerve, 2011,63 ( 1 ) : 69 -74.
-
10Delgado-Lopez PD, Marttn-Velasco V, Castilla-Diez JM, et al. Dexamethasone treatment in chronic subdural haematoma. Neurocirugia(Astur) ,2009,20 (4) :346-359.
同被引文献27
-
1Jin-young Lee, Bum-Tae Kim, Sun-Chul Hwang, et al. Indications and Surg/cal Results of Twist-Drill Craniostomy at the Pre-Coronal Point for Symptomatic Chronic Subdural Hematoma Patients [ J ]. J Korean Neuro- surg Soc,2012,52(2) :133-137.
-
2Are Hugo Pripp, Milo Stani~ic. The Correlation between Pro- and An- ti-Inflammatory Cytokines in Chronic Subdural Hematoma Patients As- sessed with Factor Analysis[ J]. PLoS 0ne,2014,9(2) :e90149.
-
3Milo Stani~ic, John Hald, Inge Andre Rasmussen, et aL Volume and densities of chronic subdural haematoma obtained from CT imaging aspredictors of postoperative reeurrence:a prospective study of 107 opera- ted patients[ J]. Acta Neuroehir (Wien) ,2013,155 (2) :323-333.
-
4Kun Hou, Chen G Li, Yang Zhang, et al. The Surgical Treatment of Three Young ChronieSubdural Hematoma Patients with Different Causes [ J]. J Korean Neurosurg Soe ,2014,55 (4) :218-22.
-
5Gun-Young Lee, Chang Hyun Oh, Yu Shik Shim, et al. Comparison of Drainage Volume of Chronic Subdural Hematoma According to Drainage Catheter Type[J]. Yonsei Med J,2013,54(5) :1091-1097.
-
6Yan Song, Zhitao Wang, Li Liu, et al. The level of circulating endotheli- al progenitor cells may be associated with the occurrence and recurrence of chronic subdural hematoma [ J ]. Clinics ( Sao Paulo ), 2013,68 (8) :1084-1088.
-
7Hyuck-Jin Oh, Kyeong-Seok Lee, Jae-Jun Shim, et al. Postoperative Course and Recurrence of Chronic Subdural Hematoma[J].J Korean Neurosurg Soc,2010,48(6) :518-523.
-
8Berghaauster Pont LM, Dammers R, Schouten JW, et al. Clinical factors associated with outcome in chronic subdural hematoma:a retrospective cohort study of patients on preoperative corticosteroid therapy[J]. Neu- rosurgery,2012,70(4) :873-80.
-
9Yong Li, Dingguo Zhang, Yuqing Zhang, et al. Augmentation of neovas- cularizatlon in routine hindlimb ischemia by combined therapy with sim- vastatin and bone marrow-derived mesenchymal stem cells transplanta- tion [ J]. J Biomed Sci ,2010,17 ( 1 ) : doi : 10.1186/1423-0127-17-75.
-
10Indraswari F,Wang H,Lei B,et al. Stainns improve outcome in murine models of intraeranial hemorrhage and traumatic brain injury:a transla- tional approach[J]. Neurotrauma,2012,29 (7) : 1388-1400.
引证文献2
-
1葛元鸿,徐学君,张新宇,郑毅.他汀类药物对慢性硬膜下血肿术后复发的影响[J].四川医学,2016,37(1):93-95. 被引量:11
-
2李东海,王崇科,方孟秋,黄毅,黄永健,梁志远.地塞米松降低慢性硬膜下血肿患者再手术率的作用分析[J].中国实用神经疾病杂志,2017,20(21):45-47. 被引量:4
二级引证文献15
-
1丁观福.辛伐他汀治疗慢性硬膜下血肿的临床效果[J].中国当代医药,2017,24(25):48-50. 被引量:1
-
2霍孜克,赵乾,张翔,李述军,张晓红.活血醒脑汤对慢性硬膜下血肿患者术后血肿清除及预后的影响[J].新中医,2018,50(2):16-20. 被引量:6
-
3王琪鸿,任新海.锥颅引流术联合阿伐他汀治疗慢性硬膜下血肿的疗效分析[J].中国临床神经外科杂志,2018,23(9):620-621. 被引量:3
-
4刘帅,王晓峰,朱峰,桂忆南,李贝贝,王怡,董龙科,张宏兵.高压氧联合阿托伐他汀在慢性硬膜下血肿钻孔手术后的应用[J].中国临床神经外科杂志,2017,22(11):779-780. 被引量:7
-
5王东挺,张学军,梁伟.阿托伐他汀联合地塞米松对慢性硬膜下血肿患者钻孔引流术后复发的影响[J].中国医学创新,2018,15(8):54-57. 被引量:12
-
6徐源,隋建美,韩锋,杨明.阿托伐他汀药物在慢性硬膜下血肿的临床研究[J].临床医药文献电子杂志,2017,4(92):18159-18160.
-
7李晓良,任光辉.钻孔引流术联合阿托伐他汀治疗慢性硬膜下血肿的效果[J].精准医学杂志,2019,34(3):234-236. 被引量:6
-
8肖罡,刘保国,黄斌,朱飚,张龙,宋启星,钟兵.他汀类药物预防慢性硬膜下血肿单孔钻孔引流术术后复发的研究[J].中国实用医药,2019,14(19):110-112. 被引量:3
-
9汪棋笙,侯黎明,李振,唐清明,李华国,刘亮.不冲洗钻孔引流联合阿托伐他汀治疗慢性硬膜下血肿的临床应用[J].系统医学,2019,4(13):1-3. 被引量:2
-
10徐涛,罗玲华.不同种类他汀药物对慢性硬膜下血肿治疗的临床效果研究[J].中国现代医生,2019,57(35):94-96. 被引量:1
-
1潘新宇,周三权,周小栋,章卫桥.早期气管切开对防治重型颅脑损伤开颅术后肺部感染的作用[J].中华创伤杂志,2005,21(8):626-626. 被引量:27
-
2李兴斗,方明磊.重症颅脑损伤67例手术后死亡原因分析[J].中国医药指南,2012,10(12):179-180.
-
3陆治强,杨华,刘窗溪.外伤性迟发性颅内血肿35例分析[J].贵州医药,2004,28(4):338-339.
-
4郝桂琴,李沁,王荣.重型继发性颅脑损伤108例护理[J].现代中西医结合杂志,2008,17(6):947-948.
-
5陈震,李爱民,刘希光,李宁,颜士卫,马逵,周辉,夏咏本,罗强.继发性颅脑损伤的高危因素与重型颅脑损伤术中恶性脑膨出的相关性分析[J].中国医师进修杂志(外科版),2009,32(12):1-3.
-
6包蕾.外伤性迟发性颅内血肿的早期观察[J].浙江临床医学,2006,8(9):998-998.
-
7张咸伟,张铁军,田玉科.术后镇痛对神经外科病人血浆内皮素-1的影响[J].中国疼痛医学杂志,2005,11(2):77-80. 被引量:5
-
8杨丽霞,赵学兰.轻型颅脑损伤的中医护理[J].中国中医急症,2004,13(11):791-791. 被引量:3
-
9周汉光,崔群建.脑外伤弥漫性脑肿胀的治疗分析[J].医学信息(医药版),2009(2):34-35. 被引量:1
-
10刘海生.闭合性颅脑损伤的分类及急救处理[J].中国社区医师,2008,24(13):10-11. 被引量:1